• Software
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • NAMVantage™
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Board of Directors
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
  • Search
Simulations Plus logo
Simulations Plus logo

Simulations Plus

We Improve Health Through Innovative Solutions

  • Software
      • GastroPlus®
      • MonolixSuite™
      • ADMET Predictor®
      • DILIsym®
      • DDDPlus™
      • NAFLDsym®
      • MembranePlus™
      • Monolix®
      • OBESITYsym™
      • PKanalix®
      • Simulx®
      • IPFsym®
      • ILDsym®
      • RENAsym®
      • Pro-ficiency
      • Panorama KOL Insights Engine
      • MedChem Designer™
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Quantitative Systems Pharmacology (QSP)
      • Physiologically Based Pharmacokinetic (PBPK) Software
      • Cheminformatics
      • Adaptive Learning Insights (ALI)
      • Medical Communications
      • Software Packages
        • Consult + Coach
        • Plug ‘n’ Play
        • Pulmonary Package
        • First-in-Human Simulator
        • EvolvePK+
        • Liver Safety+
        • NAMVantage™
      • University+
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • NAMVantage™
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Board of Directors
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
Simulations Plus to Collaborate with FDA to Develop Predictive Toxicity Models
View More
Simulations Plus to Collaborate with FDA to Develop Predictive Toxicity Models
  • January 26, 2011
  • Press Release

Simulations Plus to Collaborate with FDA to Develop Predictive Toxicity Models

Keywords: contaminants, food additives, quantitative structure–activity relationship (QSAR), research collaboration agreement (RCA), toxicity models, U.S. FDA
Division: PBPK

Center for Food Safety and Applied Nutrition (CFSAN) to Provide Data

  • Read More
Simulations Plus Reports First Quarter FY2011 Financial Results
  • January 14, 2011
  • Press Release

Simulations Plus Reports First Quarter FY2011 Financial Results

Keywords: financial results, investor relations
Division: PBPK

Pharmaceutical Software and Services Revenues Up 18%, Words+ Subsidiary Up 8.3%, Consolidated Earnings Up 32%, and EPS Up 34% from 1QFY10

  • Read More
Simulations Plus Sets Date for 1st Quarter 2011 Earnings Release and Conference Call
  • January 13, 2011
  • Press Release

Simulations Plus Sets Date for 1st Quarter 2011 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Friday, January 14, at 11:00 AM EST

  • Read More
Simulations Plus Reports Preliminary Revenues for First Fiscal Quarter of FY2011
  • December 2, 2010
  • Press Release

Simulations Plus Reports Preliminary Revenues for First Fiscal Quarter of FY2011

Keywords: earnings, investor relations
Division: PBPK

Record First Quarter and Sustained Multi-year Growth Trend

  • Read More
Simulations Plus Reports FY2010 and Fourth Quarter FY2010 Financial Results
  • November 30, 2010
  • Press Release

Simulations Plus Reports FY2010 and Fourth Quarter FY2010 Financial Results

Keywords: financial results, investor relations
Division: PBPK

Fiscal Year Earnings Jump 52.7% on 17.2% Revenue Increase

  • Read More
Simulations Plus Sets Date for 4 th Quarter and Fiscal Year 2010 Earnings Release and Conference Call
  • November 23, 2010
  • Press Release

Simulations Plus Sets Date for 4 th Quarter and Fiscal Year 2010 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Tuesday, November 30, at 4:15 PM EST

  • Read More
Simulations Plus to Present at the Rodman & Renshaw Annual Global Investment Conference
  • September 9, 2010
  • Press Release

Simulations Plus to Present at the Rodman & Renshaw Annual Global Investment Conference

Keywords: investor conference, Rodman & Renshaw Annual Global Investment Conference
Division: PBPK

Leading Provider of Simulation and Modeling Software for Pharmaceutical Discovery and Development Scheduled to Present on September 13, 2010; Rodman & Renshaw Annual Global Investment Conference NYC

  • Read More
Simulations Plus Reports Preliminary Revenues for Fourth Fiscal Quarter of FY2010
  • September 8, 2010
  • Press Release

Simulations Plus Reports Preliminary Revenues for Fourth Fiscal Quarter of FY2010

Keywords: preliminary revenues
Division: PBPK

New Record Fiscal Year Follows Record 1st, 2nd and 3rd Quarters; Rodman & Renshaw Annual Global Investment Conference NYC

  • Read More
Simulations Plus Releases GastroPlus™ Version 7.0
  • August 24, 2010
  • Press Release

Simulations Plus Releases GastroPlus™ Version 7.0

Keywords: drug absorption, drug-drug interactions (DDIs), Nasal/pulmonary drug delivery, ocular drug dosage, pharmacodynamics, pharmacokinetics
Software: GastroPlus®
Division: PBPK
  • Read More
U.S. FDA Expands DDDPlus™Software Licenses
  • August 13, 2010
  • Press Release

U.S. FDA Expands DDDPlus™Software Licenses

Keywords: dissolution rate, FDA Office of Generic Drugs, in vitro dissolution, U.S. FDA
Software: DDDPlus™
Division: PBPK
  • Read More
Simulations Plus Launches MedChem Studio
  • August 3, 2010
  • Press Release

Simulations Plus Launches MedChem Studio

Keywords: cheminformatics, drug discovery, molecular design, molecular property prediction software
Software: MedChem Studio™
Division: PBPK
  • Read More
Simulations Plus Releases Major Upgrade in ADMET Predictor 5.0
  • July 27, 2010
  • Press Release

Simulations Plus Releases Major Upgrade in ADMET Predictor 5.0

Keywords: cheminformatics, drug discovery, molecular property prediction program, molecular property prediction software, National Institutes of Health, Small Business Innovation Research (SBIR)
Software: ADMET Predictor®
Division: PBPK
  • Read More
Simulations Plus Reports Third Quarter FY2010 Financial Results
  • July 16, 2010
  • Press Release

Simulations Plus Reports Third Quarter FY2010 Financial Results

Keywords: financial results, investor relations
Division: PBPK

Another Record Quarter with Revenues up 15% and Earnings up 30% over Last Year’s Q3

  • Read More
Simulations Plus Sets Date for 3rd Quarter Fiscal Year 2010 Earnings Release and Conference Call
  • July 15, 2010
  • Press Release

Simulations Plus Sets Date for 3rd Quarter Fiscal Year 2010 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK
  • Read More
Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter of FY2010
  • June 21, 2010
  • Press Release

Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter of FY2010

Keywords: preliminary revenues
Division: PBPK

New Record Quarter of $3.1 Million Due to Sustained Growth in Revenues

  • Read More
Simulations Plus Set to Rejoin Russell Microcap Index
  • June 16, 2010
  • Press Release

Simulations Plus Set to Rejoin Russell Microcap Index

Keywords: investor relations, Russell Microcap Index
Division: PBPK
  • Read More
Simulations Plus Named “Company of the Month” by Investment Newsletter
  • May 27, 2010
  • Press Release

Simulations Plus Named “Company of the Month” by Investment Newsletter

Keywords: Company of the Month, investor relations, The Bowser Report
Division: PBPK
  • Read More
SLP Subsidiary Words+ Launches EyePro™ System
  • May 10, 2010
  • Press Release

SLP Subsidiary Words+ Launches EyePro™ System

Keywords: eye gaze systems, EyePro GS™, wholly owned subsidiary, Words+
Division: PBPK

New System Enables Users to Operate Computer Simply by Looking at It

  • Read More
Simulations Plus Reports Second Quarter FY2010 Financial Results
  • April 15, 2010
  • Press Release

Simulations Plus Reports Second Quarter FY2010 Financial Results

Keywords: financial results, investor relations
Division: PBPK

Sustained Growth in Record Second Quarter and Record First Six Months

  • Read More
Simulations Plus Sets Date for 2nd Quarter Fiscal Year 2010 Earnings Release and Conference Call
  • April 13, 2010
  • Press Release

Simulations Plus Sets Date for 2nd Quarter Fiscal Year 2010 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Thursday, April 15, at 12:00 noon EDT

  • Read More
  • «
  • 1
  • 2
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 27
  • 28
  • »
Ready to get started?

Sign-up for a free evaluation or schedule a meeting with one of our experts!

Questions? Email info@simulations-plus.com

Discuss my project needs with an expert
Schedule a software demo
Join our newsletter
Software
  • GastroPlus®
  • MonolixSuite™
  • ADMET Predictor®
  • DILIsym®
  • DDDPlus™
  • NAFLDsym®
  • MembranePlus™
  • OBESITYsym™
  • PKanalix®
  • Simulx®
  • IPFsym®
  • ILDsym®
  • MITOsym®
  • QSP Software
  • Pro-ficiency
  • Panorama KOL Insights Engine
  • MedChem Designer™
Services
  • Early Drug Discovery
  • Physiologically Based Pharmacokinetics (PBPK)
  • Quantitative Systems Pharmacology (QSP)
  • Clinical Pharmacology & Pharmacometrics (CPP)
  • Adaptive Learning & Insights (ALI)
  • Medical Communications Services
  • Concierge
  • Training and Workshops
Resource Center
  • Blog
  • Journal Articles
  • Flyers
  • Posters
  • Presentations
  • Press Releases
  • Videos
  • White Papers
  • Webinars
Investors
  • Board of Directors
  • Environmental, Social and Governance (ESG)
  • Latest Presentations
  • Press Releases
  • SEC Filings
  • Shareholder Information
  • Corporate Development Initiative
About
  • Simulations Plus
  • Contact
  • Careers
  • Leadership
  • Partners and Collaborators
  • Privacy Notice
  • Cookie Notice
  • Vision, Mission & Values
  • FCOI Policy
Support
  • Customer Portal
  • Datasheets
  • Software Installation
  • Contact Support
Simulations Plus
  • GastroPlus
  • Copyright © 2025 Simulations Plus. All Rights Reserved.
    • Privacy Notice
    • Sitemap
    • Terms of Use
    • Cookie Settings
This website uses cookies
We use cookies to enhance your browsing experience and analyze our traffic. To learn more about our use of cookies and other tracking technologies, please see our Cookie Notice and our Privacy Notice. By clicking “Accept All,” you consent to such use by us of cookies and other tracking technologies. To learn more about your privacy rights and our personal data practices, please see our Privacy Notice.
Accept All Reject AllCookie Settings
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. For more information on use of cookies or similar tracking technologies on our website: View our Cookie Notice. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept